References
(1) Crawford S, Boulet SL, Kawwass JF, Jamieson DJ, Kissin DM.
Cryopreserved oocyte versus fresh oocyte assisted reproductive
technology cycles, United States, 2013. Fertil Steril
2017;107(1):110-118.
(2) Jones BP, Saso S, Mania A, Smith JR, Serhal P, Ben Nagi J. The dawn
of a new ice age: social egg freezing. Acta Obstet Gynecol Scand
2018;97(6):641-647.
(3) Jones BP, Serhal P, Ben‐Nagi J. Social egg freezing should be
offered to single women approaching their late thirties: FOR: Women
should not suffer involuntary childlessness because they have not yet
found a partner. BJOG: An International Journal of Obstetrics &
Gynaecology 2018;125(12):1579-1579.
(4) Jones BP, Kasaven L, L’Heveder A, Jalmbrant M, Green J, Makki M, et
al. Perceptions, outcomes, and regret following social egg freezing in
the UK; a cross‐sectional survey. Acta Obstet Gynecol Scand .
2020;99(3):324-332. doi:10.1111/aogs.13763
(5) Nicoletti C, Tanturri ML. Differences in delaying motherhood across
European countries: Empirical evidence from the ECHP. European Journal
of Population/Revue européenne de Démographie 2008;24(2):157-183.
(6) Martinelli L, Busatta L, Galvagni L, Piciocchi C. Social egg
freezing: a reproductive chance or smoke and mirrors? Croat Med J 2015
Aug;56(4):387-391.
(7) Cobo A, Garrido N, Pellicer A, Remohí J. Six years’ experience in
ovum donation using vitrified oocytes: report of cumulative outcomes,
impact of storage time, and development of a predictive model for oocyte
survival rate. Fertil Steril 2015;104(6):1426-1434. e8.
(8) Devesa M, Tur R, Rodríguez I, Coroleu B, Martínez F, Polyzos NP.
Cumulative live birth rates and number of oocytes retrieved in women of
advanced age. A single centre analysis including 4500 women≥ 38 years
old. Human Reproduction 2018;33(11):2010-2017.
(9) Al-Azemi M, Killick SR, Duffy S, Pye C, Refaat B, Hill N, et al.
Multi-marker assessment of ovarian reserve predicts oocyte yield after
ovulation induction. Human reproduction 2010;26(2):414-422.
(10) Fedorcsák P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N,
et al. Impact of overweight and underweight on assisted reproduction
treatment. Human Reproduction 2004;19(11):2523-2528.
(11) Nelson SM, Klein BM, Arce J. Comparison of antimüllerian hormone
levels and antral follicle count as predictor of ovarian response to
controlled ovarian stimulation in good-prognosis patients at individual
fertility clinics in two multicenter trials. Fertil Steril
2015;103(4):923-930. e1.
(12) Vaughan DA, Harrity C, Sills ES, Mocanu EV. Serum estradiol: oocyte
ratio as a predictor of reproductive outcome: an analysis of data
from> 9000 IVF cycles in the Republic of Ireland. J Assist
Reprod Genet 2016;33(4):481-488.
(13) El-Shawarby SA, Khalaf Y. Age-specific serum FSH concentrations and
their correlation with the outcome of ovarian stimulation for IVF.
Reproductive biomedicine online 2009;18(6):750-755.
(14) Wirleitner B, Okhowat J, Vištejnová L, Králíčková M, Karlíková M,
Vanderzwalmen P, et al. Relationship between follicular volume and
oocyte competence, blastocyst development and live‐birth rate: optimal
follicle size for oocyte retrieval. Ultrasound in Obstetrics &
Gynecology 2018;51(1):118-125.
(15) Ben-Nagi J, Wells D, Doye K, Loutradi K, Exeter H, Drew E, et al.
Karyomapping: a single centre’s experience from application of
methodology to ongoing pregnancy and live-birth rates. Reproductive
BioMedicine Online 2017;35(3):264-271.
(16) Jenkins J, Drakeley A, Mathur R. The Management of Ovarian
Hyperstimulation Syndrome.RCOG Green Top Guideline no.5,
2006.Reconfirmed 2011.
(17) Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of
anti-Müllerian hormone and antral follicle count to predict the
potential of oocytes and embryos. European Journal of Obstetrics &
Gynecology and Reproductive Biology 2010;150(2):166-170.
(18) Moreau J, Gatimel N, Simon C, Cohade C, Lesourd F, Parinaud J, et
al. Age-specific anti-Mullerian hormone (AMH) levels poorly affects
cumulative live birth rate after intra-uterine insemination. European
Journal of Obstetrics & Gynecology and Reproductive Biology: X
2019;3:100043.
(19) Broer S, Dolleman M, Opmeer B, Fauser B, Mol B, Broekmans F. AMH
and AFC as predictors of excessive response in controlled ovarian
hyperstimulation: a meta-analysis. Hum Reprod Update 2010;17(1):46-54.
(20) Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik
L, Jakiel G, et al. Fertility in women of late reproductive age: the
role of serum anti-Müllerian hormone (AMH) levels in its assessment. J
Endocrinol Invest 2016;39(11):1259-1265.
(21) Barad D, Weghofer A, Goyal A, Gleicher N. Age specific
anti-müllerian hormone (AMH) levels discriminate at each age between
poorer and better oocyte yields. Fertil Steril 2009;92(3):S101.
(22) Wittemer C, Ohl J, Bailly M, Bettahar-Lebugle K, Nisand I. Does
body mass index of infertile women have an impact on IVF procedure and
outcome? J Assist Reprod Genet 2000;17(10):547-552.
(23) Zhang JJ, Feret M, Chang L, Yang M, Merhi Z. Obesity adversely
impacts the number and maturity of oocytes in conventional IVF not in
minimal stimulation IVF. Gynecological Endocrinology 2015;31(5):409-413.
(24) Christensen MW, Ingerslev HJ, Degn B, Kesmodel US. Effect of female
body mass index on oocyte quantity in fertility treatments (IVF):
treatment cycle number is a possible effect modifier. A register-based
cohort study. PloS one 2016;11(9):e0163393.
(25) Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí
J. Oocyte vitrification as an efficient option for elective fertility
preservation. Fertil Steril 2016;105(3):755-764. e8.
(26) Wennberg A, Schildauer K, Brännström M. Elective oocyte freezing
for non‐medical reasons; a six‐year report on utilization and IVF
results from a Swedish center. Acta obstetricia et gynecologica
Scandinavica. 2019 Nov;98(11):1429-34.
(27) Hammarberg K, Kirkman M, Pritchard N, Hickey M, Peate M, McBain J,
et al. Reproductive experiences of women who cryopreserved oocytes for
non-medical reasons. Human Reproduction 2017;32(3):575-581.
(28) Fertilisation H, Authority E. Fertility Treatment 2014-2015 Trends
and figures. HFEA Available at
https://www.hfea.gov.uk/media/2563/hfea-fertility-trends-and-figures-2017-v2.pdf
Accessed 2018;14(08):2018.
(29) Gurtin Z. Unscrambling HFEA data on egg freezing: where are the
missing frozen eggs. BioNews 2018:943.
(30) Andersen AN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal
age and fetal loss: population based register linkage study. BMJ
2000;320(7251):1708-1712.
(31) Jones BP, Serhal P, Ben Nagi J. Social egg freezing: Early is not
always best. Acta Obstet Gynecol Scand 2018;97(12):1531-1531.
(32) Fertilisation H, Authority E. Fertility treatment in 2013: trends
and figures. HFEA, London (Available at
http://www.hfea.gov.uk/docs/HFEA_Fertility_treatment_
Trends_and_figures_2014.pdf Last accessed: 8 May 2017) 2014.
(33) Bowen-Simpkins P, Wang JJ, Ahuja KK. The UK´ s anomalous 10-year
limit on oocyte storage: time to change the law. Reproductive
biomedicine online 2018;37(4):387-389.
(34) Nekkebroeck J, Stoop D, Devroey P. O-036 A preliminary profile of
women opting for oocyte cryopreservation for non-medical reasons. Human
Reproduction 2010;25(20100600).
(35) Greenwood EA, Pasch LA, Hastie J, Cedars MI, Huddleston HG. To
freeze or not to freeze: decision regret and satisfaction following
elective oocyte cryopreservation. Fertil Steril 2018;109(6):1097-1104.
e1.
Table 1 Demographic data and controlled ovarian stimulation
variables